Advanced Medical Solutions Group (LON:AMS) Earns “Buy” Rating from Berenberg Bank

Berenberg Bank reissued their buy rating on shares of Advanced Medical Solutions Group (LON:AMS) in a research report released on Wednesday, MarketBeat reports. They currently have a GBX 300 ($3.87) target price on the stock.

Advanced Medical Solutions Group Stock Down 3.8 %

Shares of AMS opened at GBX 196.80 ($2.54) on Wednesday. The firm has a market cap of £424.94 million, a P/E ratio of 38.14, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. Advanced Medical Solutions Group has a 12-month low of GBX 176.60 ($2.28) and a 12-month high of GBX 275.83 ($3.56). The company’s 50-day moving average price is GBX 211.70 and its 200 day moving average price is GBX 212.12. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01.

Advanced Medical Solutions Group (LON:AMS) last issued its quarterly earnings data on Thursday, March 20th. The company reported GBX 10.65 ($0.14) earnings per share (EPS) for the quarter. Advanced Medical Solutions Group had a net margin of 8.49% and a return on equity of 4.57%. On average, sell-side analysts forecast that Advanced Medical Solutions Group will post 9.8159509 earnings per share for the current year.

Advanced Medical Solutions Group Increases Dividend

The business also recently disclosed a dividend, which will be paid on Friday, June 20th. Investors of record on Thursday, May 29th will be issued a GBX 1.83 ($0.02) dividend. This is a positive change from Advanced Medical Solutions Group’s previous dividend of $0.77. This represents a yield of 0.89%. The ex-dividend date of this dividend is Thursday, May 29th. Advanced Medical Solutions Group’s payout ratio is 38.76%.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.